AI Inventors - DABUS, Thaler and the Commissioner - The World's first case to find for the Robot

In this webinar brought to you by AUSCL (Australian Society for Computers and Law) and Melbourne University's CAIDE (Centre for Artificial Intelligence and Digital Ethics).
We explore the Decision in Thaler v Commissioner of Patents [2021] FCA 879 - The world's first judicial determination in the world in favour of AI systems being named as inventors of a patent.
Featuring
Mr David Shavin QC - Lead barrister
Professor Ryan Abbott - The Artificial Inventor Project (AIP) leader
Professor Jeannie Paterson - Professor of Law at the University of Melbourne and Co-Director of the Centre for AI and Digital Ethics.
The case
Thaler v Commissioner of Patents [2021] FCA 879 www.austlii.edu...
Speaker bios
David SHAVIN QC
David practices primarily in Patent Law and Intellectual Property generally, Competition, Telecommunications, Administrative, Corporations and Commercial Law in both trial and appellate work predominantly in the Federal and High Courts. Over the last 43 years, David has had extensive trial and appellate experience in Australia in the Federal Court and High Court, and in New Zealand in the superior courts, focused heavily, but not exclusively, on patents (especially pharmaceutical and life sciences, and computer implemented inventions) on trademarks and competition and administrative law. Recent cases of note include Myriad and Calidad in the High Court; and in the Federal Court: Sequenom, Federal Treasury Enterprises, Encompass, Rokt, Aristocrat and Thaler. He also has trial and appellate experience in the Supreme Court of Victoria, especially in the Commercial Court, and in the Equity Division of the NSW Supreme Court. He has appeared in a number of landmark patent, trade mark and competition cases as a silk over the last 27 years.
In New Zealand where David was appointed silk in 1994, his appearance work in the High Court, Court of Appeal and Supreme Court has focused heavily on competition and regulatory work but includes some patent and trademark work. He appeared for Transpower in NZ in the input methodologies litigation and Pfizer in the Viagra patent litigation.
For nine years he lectured in the Masters programs at Melbourne Business School, Melbourne University and Monash University in Advanced Trade Practices Law with the late Prof Maureen Brunt, the late Professor Baxt and Professors Fels, Williams, and Officer. David has been an accredited LEADR Mediator and the former Trade Practices Editor of the ABLR. David is also admitted in New Zealand.
Professor Ryan Abbott
Ryan Abbott, MD, JD, MTOM, PhD, is Professor of Law and Health Sciences at the University of Surrey School of Law, Adjunct Assistant Professor of Medicine at the David Geffen School of Medicine at UCLA, partner at Brown, Neri, Smith & Khan, LLP, and a mediator and arbitrator with JAMS, Inc. He is the author of “The Reasonable Robot: Artificial Intelligence and the Law” published in 2020 by Cambridge University Press. He has published widely on issues associated with life sciences and intellectual property in leading legal, medical, and scientific books and journals, and his research has been featured prominently in the popular press including in The Times, the New York Times, the Financial Times, and other media outlets involving time. Professor Abbott has worked as an expert for, among others, the United Kingdom Parliament, the European Commission, the World Health Organization, and the World Intellectual Property Organization. He is a licensed physician and patent attorney in the United States, and a solicitor advocate in England and Wales. Managing Intellectual Property magazine named him as one of the fifty most influential people in intellectual property in 2019. www.ryanabbott.com